These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 6478405

  • 1. Nuclear roundness factor. A predictor of progression in untreated Stage A2 prostate cancer.
    Epstein JI, Berry SJ, Eggleston JC.
    Cancer; 1984 Oct 15; 54(8):1666-71. PubMed ID: 6478405
    [Abstract] [Full Text] [Related]

  • 2. A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis.
    Partin AW, Walsh AC, Pitcock RV, Mohler JL, Epstein JI, Coffey DS.
    J Urol; 1989 Nov 15; 142(5):1254-8. PubMed ID: 2810502
    [Abstract] [Full Text] [Related]

  • 3. Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer.
    Partin AW, Steinberg GD, Pitcock RV, Wu L, Piantadosi S, Coffey DS, Epstein JI.
    Cancer; 1992 Jul 01; 70(1):161-8. PubMed ID: 1606538
    [Abstract] [Full Text] [Related]

  • 4. A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness.
    Diamond DA, Berry SJ, Jewett HJ, Eggleston JC, Coffey DS.
    J Urol; 1982 Oct 01; 128(4):729-34. PubMed ID: 7143594
    [Abstract] [Full Text] [Related]

  • 5. Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer.
    Diamond DA, Berry SJ, Umbricht C, Jewett HJ, Coffey DS.
    Prostate; 1982 Oct 01; 3(4):321-32. PubMed ID: 7122329
    [Abstract] [Full Text] [Related]

  • 6. Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. II. Standardization of methodology for histologic sections.
    Mohler JL, Partin AW, Epstein JI, Lohr WD, Coffey DS.
    J Urol; 1988 May 01; 139(5):1085-90. PubMed ID: 3283380
    [Abstract] [Full Text] [Related]

  • 7. Nuclear shape analysis for the assessment of local invasion and metastases in clinically localized prostate carcinoma.
    Mohler JL, Figlesthaler WM, Zhang XZ, Partin AW, Maygarden SJ.
    Cancer; 1994 Dec 01; 74(11):2996-3001. PubMed ID: 7954263
    [Abstract] [Full Text] [Related]

  • 8. Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. I. Testing of a digitization system.
    Mohler JL, Partin AW, Lohr WD, Coffey DS.
    J Urol; 1988 May 01; 139(5):1080-4. PubMed ID: 3361653
    [Abstract] [Full Text] [Related]

  • 9. Nuclear morphology of prostatic carcinoma: comparison of computerized image analysis (CAS 200) versus video planimetry (DynaCELL).
    Armas OA, Pizov G, Pitcock RV, Partin AW, Epstein JI.
    Mod Pathol; 1991 Nov 01; 4(6):763-7. PubMed ID: 1788268
    [Abstract] [Full Text] [Related]

  • 10. Nuclear morphometry in automatic biopsy and radical prostatectomy specimens of prostatic carcinoma. A comparison.
    Mohler JL, Metts JC, Zhang XZ, Maygarden SJ.
    Anal Quant Cytol Histol; 1994 Dec 01; 16(6):415-20. PubMed ID: 7710616
    [Abstract] [Full Text] [Related]

  • 11. Prediction of prognosis in untreated stage A2 prostatic carcinoma.
    Mohler JL, Partin AW, Epstein JI, Becker RL, Mikel UV, Sesterhenn IA, Mostofi FK, Gleason DF, Sharief Y, Coffey DS.
    Cancer; 1992 Jan 15; 69(2):511-9. PubMed ID: 1728382
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of nuclear roundness as a tool for prostatic carcinoma grading].
    López A, Vilches J, Alvarez-Ossorio J, Aparicio J, Ronco A, Castiñeiras J.
    Actas Urol Esp; 1992 Sep 15; 16(8):620-6. PubMed ID: 1462810
    [Abstract] [Full Text] [Related]

  • 13. Semiautomated nuclear shape analysis of prostatic carcinoma and benign prostatic hyperplasia.
    Kim D, Charlton JD, Coggins JM, Mohler JL.
    Anal Quant Cytol Histol; 1994 Dec 15; 16(6):400-14. PubMed ID: 7536003
    [Abstract] [Full Text] [Related]

  • 14. Frequencies of different nuclear morphological features in prostate adenocarcinoma.
    Rashid F, Ul Haque A.
    Ann Diagn Pathol; 2011 Dec 15; 15(6):414-21. PubMed ID: 21849255
    [Abstract] [Full Text] [Related]

  • 15. Significant variations in nuclear structure occur between and within Gleason grading patterns 3, 4, and 5 determined by digital image analysis.
    Veltri RW, Marlow C, Khan MA, Miller MC, Epstein JI, Partin AW.
    Prostate; 2007 Aug 01; 67(11):1202-10. PubMed ID: 17525934
    [Abstract] [Full Text] [Related]

  • 16. [Histologic-cytologic grading of uniform and pluriform prostate cancers].
    Helpap B, Otten J.
    Pathologe; 1982 Jul 01; 3(4):216-22. PubMed ID: 7111221
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of nuclear shape in aspirated and histologic specimens of prostatic carcinoma.
    Tardif CP, Partin AW, Qaqish B, Epstein JP, Mohler JL.
    Anal Quant Cytol Histol; 1992 Dec 01; 14(6):474-82. PubMed ID: 1292446
    [Abstract] [Full Text] [Related]

  • 18. Ability to predict biochemical progression using Gleason score and a computer-generated quantitative nuclear grade derived from cancer cell nuclei.
    Veltri RW, Miller MC, Partin AW, Coffey DS, Epstein JI.
    Urology; 1996 Nov 01; 48(5):685-91. PubMed ID: 8911509
    [Abstract] [Full Text] [Related]

  • 19. Chromatin changes predict recurrence after radical prostatectomy.
    Hveem TS, Kleppe A, Vlatkovic L, Ersvær E, Wæhre H, Nielsen B, Kjær MA, Pradhan M, Syvertsen RA, Nesheim JA, Liestøl K, Albregtsen F, Danielsen HE.
    Br J Cancer; 2016 May 24; 114(11):1243-50. PubMed ID: 27124335
    [Abstract] [Full Text] [Related]

  • 20. Correlation of prognosis to nuclear roundness and to flow cytometric light scatter.
    Mohler JL, Partin AW, Coffey DS.
    Anal Quant Cytol Histol; 1987 May 24; 9(2):156-64. PubMed ID: 3300686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.